Skip to Content

VANFLYTA 17.7 mg film-coated tablets

Licence status
Authorised: 06/11/2023
Active substances
QUIZARTINIB DIHYDROCHLORIDE
Dosage Form
Film-coated tablet
Licence number
EU/1/23/1768/001-002
Licence holder
Daiichi Sankyo Europe GmbH

Licence information

ATC code
L01EX11 quizartinib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
06/11/2023